GSC
ASMB icon

Ground Swell Capital’s Assembly Biosciences ASMB Stock Holding History

Ground Swell Capital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$1K Sell
12
-85
-88% -$7.54K ﹤0.01% 2080
2014
Q2 		$8K Buy
+97
New +$6.88K 0.02% 826

Other funds holding ASMB

VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AMCA
Arthur M. Cohen & Associates Northbrook, Illinois $563M AUM 20.97% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GTC
Ghost Tree Capital New York $331M AUM 70.11% 1-Year Est. Return
IHM
Iguana Healthcare Management New York $152M AUM 48.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ground Swell Capital's ASMB Position: Q3 2014 in Review

Ground Swell Capital reduced its Assembly Biosciences (ASMB) stake by 88% in Q3 2014, selling an estimated $7.54K and leaving 12 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2080.

Ground Swell Capital first reported a position in ASMB in Q2 2014 and has held it in 2 quarters since. The position peaked at $8K in Q2 2014. 22 funds tracked by Wall St. Rank hold ASMB as of Q3 2014.

  • Ground Swell Capital held 12 shares of Assembly Biosciences worth $1K as of Q3 2014.
  • Ground Swell Capital sold 85 Assembly Biosciences shares in Q3 2014, an estimated $7.54K.
  • Assembly Biosciences made up ﹤0.01% of Ground Swell Capital's portfolio in Q3 2014, its #2080 holding.
  • Ground Swell Capital first reported a position in Assembly Biosciences in Q2 2014 and has held it in 2 quarters since.
  • Ground Swell Capital's Assembly Biosciences position peaked at $8K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2014.

Based on Ground Swell Capital's 13F filing for Q3 2014, filed 6 Nov 2014.